Global Diabetes Treatments Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 5,370.20 Million |
 Market Size (Forecast Year) |
USD 8,920.90 Million |
 CAGR |
% |
| Major Markets Players |
|
>全球糖尿病治疗市场，按糖尿病类型（1 型、2 型）、产品（胰岛素、口服降血糖药、非胰岛素注射药）、设备（血糖仪和试纸、连续血糖监测仪(CGM)、闪光血糖监测设备、注射笔、胰岛素泵、自动胰岛素输送系统）、最终用户（医院、个人使用、诊所）划分 - 行业趋势和预测到 2030 年。
糖尿病治疗市场分析和规模：
糖尿病的日益流行和创新糖尿病治疗技术的进步显著改善了糖尿病治疗市场的设计和功能，为糖尿病治疗市场的增长铺平了道路。糖尿病治疗市场一直稳步增长，原因有几个。首先，医疗保健支出的增加是市场增长的驱动力。此外，老年人口的增加也促进了糖尿病治疗市场的发展。
Data Bridge Market Research 分析，全球糖尿病治疗市场规模在 2022 年为 53.702 亿美元，到 2030 年将飙升至 89.209 亿美元，预计在预测期内的复合年增长率为 6.5%。1 型糖尿病在糖尿病治疗市场中占据主导地位，这是因为技术的进步推动了各种用途的糖尿病治疗的发展。除了对市场价值、增长率、细分市场、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。
糖尿病治疗市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2015-2020) |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
按糖尿病类型（1 型、2 型）、产品（胰岛素、口服降糖药、非胰岛素注射药）、设备（血糖仪和试纸、连续血糖监测仪 (CGM)、闪光血糖监测设备、注射笔、胰岛素泵、自动胰岛素输送系统）、最终用户（医院、个人使用、诊所）、 |
|
覆盖国家 |
美国、加拿大、墨西哥、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区 |
|
涵盖的市场参与者 |
Roche Products Limited (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Sanofi-Deutschland GmbH (Germany), Novo Nordisk A/S (Germany), ARKRAY USA, Inc. (U.S.), Bayer AG (U.S.), Amylin Pharmaceuticals Inc. (U.S.), Abbott (U.S.), Medtronic Inc. (U.S.), Teva Pharmaceuticals Pvt Ltd.(U.S.), Home Diagnostics Inc. (U.S.), Novartis AG. (U.S.), Eli Lilly and Company. (U.S.), Merck & Co., Inc, .(U.S.), AstraZeneca (U.K.), Boehringer Ingelheim International GmbH (Germany), Takeda Pharmaceutical Company Limited (Japan) |
|
Market Opportunities |
|
Market Definition
The global diabetes treatments market refers to the market for products, medications, devices, and therapies used to treat and manage diabetes. Diabetes is a chronic medical condition characterized by high blood sugar levels resulting from the body's inability to produce or effectively use insulin, a hormone responsible for regulating blood glucose levels.
Global Diabetes Treatments Market Dynamics
Drivers
- Increasing prevalence of diabetes
The rising prevalence of diabetes worldwide is a significant driver for the market. The disease is reaching epidemic proportions due to sedentary lifestyles, unhealthy diets, and an aging population. As the number of people with diabetes grows, the demand for effective treatments and management options increases.
- Growing awareness and education
Increased awareness about diabetes and its complications has driven the demand for diabetes treatments. Education campaigns and initiatives by healthcare organizations, governments, and patient advocacy groups have led to earlier diagnosis, better management practices, and increased demand for effective treatment options.
- Technological advancements
Advances in medical technology have led to the development of innovative diabetes treatments. Continuous glucose monitoring systems, insulin pumps, and other devices have improved the management of diabetes and enhance patient outcomes. Technological advancements continue to drive the market by offering more precise and convenient treatment options.
Opportunities
- Rising Healthcare Expenditure
Global healthcare expenditure is rising, driven by increased healthcare access, economic growth, and government initiatives to improve healthcare infrastructure. As a result, more resources are being allocated to diabetes management and treatment, which fuels market growth.
- Government Initiatives and Support
Governments worldwide are implementing initiatives to combat diabetes and its complications. These initiatives include awareness campaigns, early screening programs, reimbursement policies, and incentives for developing and adopting innovative treatments.
Restraints/ Challenges
- High cost of diabetes treatments
Diabetes management requires long-term medication, monitoring devices, and insulin therapy, which can be expensive for many patients. The high cost of diabetes treatments can limit access to proper care, particularly in developing countries or for individuals with limited financial resources.
- Limited reimbursement policies:
In certain regions, reimbursement policies may not adequately cover the costs associated with diabetes treatments. This can create a barrier for patients to access necessary medications and technologies, leading to suboptimal management of their condition.
This Global diabetes treatments market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Global diabetes treatments market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In May 2023, Abbott announced a series of new programs within its multi-million-dollar initiative to increase diversity in clinical trials and improve care among under-represented populations. The new additions to Abbott's Diversity in Clinical Trials initiative build on the partnerships, scholarships, and the focus on diversified participants in the company's clinical trials during the initiative's first year
- In December 2022, Merck KGaA, a leading science and technology company, announced a research collaboration and commercial license agreement with Mersana Therapeutics, Inc., Cambridge, Massachusetts, USA to discover novel antibody-drug conjugates (ADCs) leveraging Mersana's proprietary Immunosynthen STING-agonist ADC platform, directed against up to two targets
Global Diabetes Treatments Market Scope
The global diabetes treatments market is segmented on the basis of type, product, devices, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Type 1
- Type 2
Product
- Insulin
- Oral Hypoglycemic Drugs
- Non-Insulin Injectable Drugs
Devices
- Blood Glucose Meters and Strips
- Continuous Glucose Monitors (CGMs)
- Flash Glucose Monitoring Device
- Injection Pens
- Insulin Pumps
- Automated Insulin Delivery Systems
End user
- Hospital
- Personal Use
- Clinic
Global diabetes treatments market regional analysis/insights
The global diabetes treatments market is analysed and market size insights and trends are provided product type, application, and end user, as referenced above.
The countries covered in the global diabetes treatments market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, and Rest of Middle East and Africa.
North America dominates the diabetes treatments market due to major key players, high disposable income, high healthcare expenditure, and well-developed healthcare sector in this region.
Asia-Pacific is expected to grow during the forecast period of 2023-2030 due to the increasing research and development activities, rising investment in the healthcare sector, and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The Global diabetes treatments market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Global diabetes treatments market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Global diabetes treatments market. The data is available for historic period 2015-2020.
Competitive Landscape and Global diabetes treatments market share Analysis
The Global diabetes treatments market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the global diabetes treatments market are:
- Roche Products Limited (Switzerland)
- Johnson & Johnson Services, Inc. (U.S.)
- Sanofi-Deutschland GmbH (Germany)
- 诺和诺德公司（德国）
- ARKRAY USA, Inc.（美国）
- 拜耳公司（美国）
- Amylin Pharmaceuticals Inc.（美国）
- 雅培（美国）
- 美敦力公司 (美国)
- Teva Pharmaceuticals Pvt Ltd.（美国）
- Home Diagnostics Inc.（美国）
- 诺华公司（美国）
- 礼来公司。（美国）
- 默克公司（美国）
- 阿斯利康（英国）
- 勃林格殷格翰国际有限公司 (德国)
- 武田药品工业株式会社 (日本)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
